Skip to content
New: the 2-minute perimenopause symptom check
For practitionersSymptom check

Guides

Non-hormonal treatments

Prescription and non-prescription options for women who cannot or do not want to take hormones.

Non-hormonal

CBT for menopause symptoms: what it treats and how to get it

Cognitive behavioral therapy for hot flashes, night sweats, and menopausal insomnia: what the MENOS and MsFLASH trials found, formats, and how to find a program.
Non-hormonal

Clinical hypnosis for hot flashes

Clinical hypnosis for hot flashes: what the 187-woman Baylor trial found versus an active control, how sessions work, who it suits, and how to find a provider.
Non-hormonal

Fezolinetant (Veozah) for hot flashes

How fezolinetant (Veozah) works, what the SKYLIGHT trials showed versus placebo, the FDA liver warning and blood test schedule, side effects, and US cost.
Non-hormonal

Gabapentin for hot flashes and sleep

Gabapentin for hot flashes and night sweats: trial results versus placebo and estrogen, doses from 900 to 2,400 mg, bedtime dosing for sleep, side effects, and cost.
Non-hormonal

Managing menopause symptoms after breast cancer: non-hormonal options

Non-hormonal options for hot flashes and vaginal symptoms after breast cancer: venlafaxine, gabapentin, oxybutynin, elinzanetant, CBT, and tamoxifen cautions.
Non-hormonal

Non-hormonal treatments for hot flashes: the full menu

Non-hormonal hot flash treatments with real evidence (fezolinetant, elinzanetant, SSRIs/SNRIs, gabapentin, oxybutynin, CBT, hypnosis) and the ones that do not work.
Non-hormonal

SSRIs and SNRIs for hot flashes

Which antidepressants reduce hot flashes, how much versus placebo, doses used in trials, side effects, the tamoxifen interaction, and what is FDA-approved.
Non-hormonal

Vaginal moisturizers and lubricants: how to choose

Choosing vaginal moisturizers and lubricants for menopausal dryness: moisturizer vs lubricant, osmolality and pH, ingredients to avoid, and what trials show.

Overview

If you cannot or prefer not to take hormones, there are non-hormonal treatments with strong evidence. The Menopause Society’s 2023 position statement gives its highest (Level I) recommendation to five options for hot flashes: cognitive behavioral therapy, clinical hypnosis, SSRIs and SNRIs, gabapentin and fezolinetant. Elinzanetant was approved in October 2025, and for vaginal dryness, moisturizers and lubricants are first-line. Hormone therapy is still the most effective treatment for hot flashes, so these options mainly serve women for whom estrogen is not the right fit.

Where to start

For the full menu in one place, including FDA status and how the options compare, read non-hormonal treatments for hot flashes. If you want a drug designed for hot flashes, see fezolinetant (Veozah). If you would rather avoid medication altogether, start with CBT for menopause symptoms. After breast cancer, go straight to non-hormonal options for breast cancer survivors.

The options at a glance

OptionHow it worksOften a fit forRead the guide
Fezolinetant (Veozah)Blocks the neurokinin 3 receptor in the brain’s temperature centerModerate to severe hot flashes; needs liver blood testsFezolinetant (Veozah)
SSRIs and SNRIsLow-dose antidepressants; paroxetine 7.5 mg is the FDA-approved oneMild to moderate relief, especially with low mood or anxietySSRIs and SNRIs for hot flashes
GabapentinAppears to act on the brain’s temperature center; sedatingNight sweats, with the largest dose at bedtimeGabapentin for hot flashes and sleep
Cognitive behavioral therapyReduces how much hot flashes bother you and disrupt sleepWomen who want no medication; pairs with any drugCBT for menopause symptoms
Clinical hypnosisGuided, focused relaxation with cooling imageryWomen who want no medicationClinical hypnosis for hot flashes
Moisturizers and lubricantsMoisturizers used on a schedule; lubricants at the time of sexMild vaginal dryness and painful sexVaginal moisturizers and lubricants

What does not work

The same position statement does not recommend supplements or herbal remedies, soy foods or extracts, cannabinoids or acupuncture for hot flashes, because trials have not shown a reliable benefit over placebo. Placebo improvement in hot flash trials is large, which is why so many products seem to work in reviews and anecdotes. The supplements guides look at popular ingredients one by one.

How to choose

Match the option to your whole picture. If night sweats and sleep are the main problem, gabapentin at bedtime or CBT for insomnia address both. If you also have low mood or anxiety, an SSRI or SNRI may do double duty. If you take tamoxifen, avoid paroxetine and fluoxetine. Prescription options typically start working within two weeks, and behavioral treatments have no drug interactions, so they can be combined with any medication. To weigh these against estrogen, see what is hormone therapy.

A clinician who sees a lot of menopause will know these trade-offs. Use the symptom check to summarize what bothers you most, then look for a clinician in the directory or read how to find a menopause specialist.

Frequently asked questions

What is the most effective non-hormonal treatment for hot flashes?

In placebo-controlled trials, fezolinetant, elinzanetant and higher-dose gabapentin produce the largest reductions in hot flash frequency, while SSRIs and SNRIs give mild to moderate relief. Clinical hypnosis showed large reductions in one well-designed trial. No head-to-head trials rank them all, so the best choice depends on your other symptoms, health history and side-effect tolerance.

Which non-hormonal drugs are FDA-approved for hot flashes?

Three: low-dose paroxetine 7.5 mg (2013), fezolinetant (2023) and elinzanetant (October 2025). Other options, including venlafaxine, escitalopram, gabapentin and oxybutynin, are prescribed off-label. Off-label use is legal and common; it means the hot flash dose was established in independent trials rather than through FDA review.

Do supplements work for menopause hot flashes?

The Menopause Society's 2023 position statement reviewed black cohosh, soy, equol and other herbal products and did not recommend any of them, citing limited or inconsistent evidence. Placebo response in hot flash trials is high, which is why many products seem to help in uncontrolled settings.

What are the non-hormonal options after breast cancer?

Venlafaxine, gabapentin, oxybutynin, CBT and clinical hypnosis all have randomized trials in breast cancer survivors, and elinzanetant was tested in women taking endocrine therapy for breast cancer. Paroxetine and fluoxetine should be avoided with tamoxifen. For vaginal dryness, moisturizers and lubricants come first.

  1. The Menopause Society. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society. Menopause, 2023
  2. U.S. Food and Drug Administration. FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause. 2023
  3. U.S. Food and Drug Administration. Novel Drug Approvals for 2025 (elinzanetant, Lynkuet). 2025
  4. The Menopause Society. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society. Menopause, 2020

Coming soon